2 report a pump system that circulates liquid metal up to a record temperature of 1,673 kelvin. The system consists of a graphite reservoir that stores liquid tin, a graphite piping network and a ceramic pump. The reservoir feeds liquid tin into the pump, where a pair of gears pressurizes the liquid, forcing it through the piping and back into the reservoir. The orange and white arrows indicate the flow of the liquid tin and the rotation of the gears, respectively. b, During operation, the pump, the motor driving the pump and the parts connecting the pump and motor become misaligned as a result of thermal expansion. The red regions indicate the position of the system at the operating temperature -the authors observe more than 1 millimetre of vertical displacement. Amy et al. purposefully misalign the pump system in the vertical direction at room temperature to account for expansion when the system is hot. (Figure adapted Undoubtedly, each pump system will need to be optimized with respect to both design and material choice according to the specific liquid metal that is circulated and the needs of the targeted application. As stated by the authors, the high-temperature chemical compatibility between candidate structural mater ials and the liquid metal is a prerequisite for extreme-temperature liquid-metal pumping. This chemical compatibility must be investigated by long-term tests under variable conditions before a decision can be made about the suitability of a particular pump system. Such studies require an investment of time and resources by industry.
complex geometry and are characterized by an exceptional compatibility (a lack of chemical reactivity) with liquid metals.
Undoubtedly, each pump system will need to be optimized with respect to both design and material choice according to the specific liquid metal that is circulated and the needs of the targeted application. As stated by the authors, the high-temperature chemical compatibility between candidate structural mater ials and the liquid metal is a prerequisite for extreme-temperature liquid-metal pumping. This chemical compatibility must be investigated by long-term tests under variable conditions before a decision can be made about the suitability of a particular pump system. Such studies require an investment of time and resources by industry.
Amy and co-workers' pump system paves the way for technological breakthroughs that could have a substantial financial impact on technologies that use liquid metals. These technologies range from concentrated solar power, thermal-energy storage and liquiddroplet heat exchangers to gas-turbine-blade cooling and various metal-processing methods. The nuclear industry could also benefit from the authors' innovation: designing reliable pumps is key to the development and efficient operation of nuclear reactors cooled by heavy liquid metals, such as the 
M A R T S A
besity is a serious global-health problem: more than 2 billion people are overweight, roughly equivalent to every fourth person in the world (go.nature. com/2xh1coq). This condition is a major and growing health-care burden, predisposing people to diseases ranging from osteoarthritis to cardiovascular disease. Four papers, one 1 on page 255 and three [2] [3] [4] in Nature Medicine, report the discovery of the receptors for a secreted protein known as growth and differentiation factor 15 (GDF15), which acts as a regulator of body weight. These receptors might serve as a biological target for therapeutics for some of the disorders that can lead to obesity.
GDF15 is a member of the large transforming growth factor-β (TGF-β) superfamily of proteins 5 . Mice that overexpress GDF15 show reduced food intake and body weight compared with wild-type mice, and do not develop obesity and insulin resistance 6 ,
OBESITY

Receptors identified for a weight regulator
The discovery of the receptors for the protein GDF15 suggests that it regulates food uptake through the emergency pathway -a neuronal circuit that causes weight loss in response to cancer, tissue damage and stress. See Letter p. whereas GDF15-deficient mice fed a standard diet have increased fat mass and body weight 5 . Blood plasma concentrations of GDF15 in mice and humans are elevated in injury, cardiovascular disease, chronic kidney disease and cancer 5 . Moreover, increased plasma levels of GDF15 correlate with decreased body mass in people with advanced cancer 7 and with a reduced body-mass index in healthy human twins 8 . But the mode of action and signalling of GDF15 has been difficult to unravel, because the receptors to which it binds were unknown.
Most proteins in the TGF-β superfamily activate transmembrane proteins called serine-threonine kinase receptors. However, glial-cell-line-derived neurotrophic factors (GDNFs) -the family of four TGF-β proteins that is evolutionarily most distant from the other members of the superfamily -use an entirely different signalling system. They bind to a group of receptors called GDNF family receptor-α (GFR-α), which attach to cell membranes through a glycolipid linkage. The resulting complex, in turn, binds to and activates a transmembrane tyrosine kinase receptor known as RET, which can activate the MAPK, AKT and PLC-γ signalling pathways. For example, GDNF (the first member of the GDNF family identified) binds to GFR-α1 and activates the RET-dependent signalling pathways that regulate kidney development, sperm production and the development and maintenance of various neuronal populations in the peripheral and central nervous systems 9 (Fig. 1a) . Hsu et al. and Yang et al. 4 have now independently identified an evolutionarily distant member of the GFR-α family 10 , dubbed GDNF receptor-α-like (GFRAL), as the receptor for GDF15, and demonstrated that GDF15-GFRAL signalling controls body weight. All four research groups show that it does not bind GDNF-family members, but does bind to GDF15, with high affinity. Furthermore, three of the groups 1, 3, 4 find that the GDF15-GFRAL complex binds to and activates RET in the same way as RET is activated by GDNF-GFR-α complexes, inducing the same signalling pathways (Fig. 1b) .
The discovery 1,3,4 that GDF15 signalling is mediated by GFRAL through RET, rather than through conventional TGF-β serine-threonine kinase receptors, is in some respects surprising, and suggests that the evolutionary distance between the serine-threonine kinase and the tyrosine kinase signalling systems might not be as great as was thought. In other respects, however, it is not entirely unexpected, because earlier investigations 5 had shown that GDF15 can activate AKT and MAPK pathways, and studies 11, 12 in which mice were genetically engineered to 'knock out' GDNF and RET indicated that there must be RET-activating proteins other than the GDNF family.
Hsu and colleagues obtained the X-ray crystal structure of GDF15 in complex with the extracellular domain of GFRAL. Although the general features of the overall structure are evolutionarily conserved relative to those of GDNF-GFR-α complexes 13 (such as GDNF-GFR-α1 and artemin-GFR-α3), there were several surprising differences. The biggest of these is that the angle between the GDF15 monomers in the complex is significantly different from the equivalent angle in the GDNF-GFR-α1 and artemin-GFR-α3 complexes 13 ( Fig. 1b) , so that the two 'wings' of the structure are almost twice as close together as they are in artemin-GFR-α3. This means that GDF15-dependent RET signalling could be substantially different from RET signalling by GDNFs. All four research groups generated mice in which the Gfral gene was knocked out, and thus observed that GFRAL is indeed required for GDF15-mediated control of body weight. Three of the groups 1, 3, 4 found that the Gfralknockout mice showed no difference in food intake, energy expenditure or body weight compared with wild-type mice when fed a normal diet. However, the mutant mice gained more weight and were more glucose intolerant than wild-type littermates when fed a high-fat diet. All four studies showed that GFRAL is expressed in neurons in only two regions of the brainstem in mice, and that a neuronal circuit that involves the parabrachial nucleus and the central amygdala (PBN-CeA) is activated by GDF15 through GFRAL. Activation of the PBN-CeA circuit causes people to stop eating under normal conditions, but also causes weight loss in cancer and in response to tissue damage and stress 14 . It is therefore often called the emergency pathway 15 . Taken together, these observations suggest that GDF15 activates the PBN-CeA neuronal circuit, which in turn regulates food consumption and body weight. To test this hypothesis, Hsu and colleagues injected the chemotherapeutic agent cisplatin -which induces the emergency pathway -in Gfral-knockout mice and in wild-type mice. In the latter animals, cisplatin increased blood serum levels of GDF15, causing weight loss and reductions in fat. By contrast, the Gfral-knockout mice resisted all of these effects, and ate just as well as the mice not injected with cisplatin, thus confirming the authors' hypothesis.
The findings raise many questions for future research. We now know the structure of the GDF15-GFRAL complex, but what is the structure of the ternary complex that this forms with RET? Which of the three major RET-dependent signalling pathways activated by GDF15 is important for controlling body weight? Given that RET is expressed in many different tissues, experiments in which it is knocked out from certain brain areas should also be performed to work out the effects on body weight, food intake and parameters of glucose metabolism (tolerance and blood levels).
GDF15 protects dopamine neurons in animal models of Parkinson's disease 16 , and GDF15-deficient mice exhibit progressive postnatal loss of various motor and sensory neurons 17 . How do these things happen when the neurons involved do not express GFRAL? There are two possibilities. If the extracellular domain of GFRAL can be cleaved off the receptor, it could circulate through the bloodstream to activate these neurons along with circulating GDF15; a similar cleavage event (GFR-α1), which attaches to cell membranes through a glycolipid linkage. The resulting complex triggers the dimerization and phosphorylation of RET, a transmembrane tyrosine kinase receptor, activating downstream signalling pathways. This process regulates kidney development, sperm formation and the development and maintenance of several neuronal populations. P represents phosphate groups. b, Four papers [1] [2] [3] [4] report that another dimeric protein, growth differentiation factor 15 (GDF15), binds with high affinity to a transmembrane receptor known as GDNF family receptor-α-like (GFRAL). The GDF15-GFRAL complex also binds to and activates RET, and induces the same signalling pathways to regulate food consumption and body weight through neurons in the brainstem. 'Crosstalk' between the signalling in a and b does not occur, because GDF15 cannot bind GFR-α1, and GDNF cannot bind GFRAL.
occurs in GFR-α1. To prove this possibility, the extracellular domain of GFRAL needs to be detected in the bloodstream and in tissues where GFRAL is not normally expressed. Alternatively, several groups have shown 9 that both GDNF and GFR-α1 signal independently of RET, so maybe GDF15 does, too.
The discovery of the receptors for GDF15, and the fact that increases in GDF15 levels are associated with weight loss in many diseases, opens up possibilities for therapeutic intervention -not only in obesity, but also in palliative cancer care, by modifying the amount of GDF15-GFRAL-RET signalling.
